Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer.

Published in: ACS medicinal chemistry letters (2024)

Provided herein are novel imidazopyridine compounds as ERK5 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

Keyphrases

papillary thyroid
signaling pathway
squamous cell
cell proliferation
pi k akt
childhood cancer